LMT
40
-2
DFS
70
-4
SYK
73
5
TGNA
59
-5
XOM
48
-2
V
70
2
OI
45
-5
NSC
62
-3
HON
73
3
MRO
43
-3
AEP
45
-2
ABT
60
-2
MAC
65
-9
NTAP
64
-2
CME
61
2
SEE
52
-3
AME
75
6
SE
65
11
M
31
-2
MMC
65
3
LMT
40
-2
DFS
70
-4
SYK
73
5
TGNA
59
-5
XOM
48
-2
V
70
2
OI
45
-5
NSC
62
-3
HON
73
3
MRO
43
-3
AEP
45
-2
ABT
60
-2
MAC
65
-9
NTAP
64
-2
CME
61
2
SEE
52
-3
AME
75
6
SE
65
11
M
31
-2
MMC
65
3
Financhill
Back

Zealand Pharma AS 10K Form

Sell
49

ZLDPF
Zealand Pharma AS

Last Price:
118.11
Seasonality Move:
5.91%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ZLDPF News And Ratings

See the #1 stock for the next 7 days that we like better than ZLDPF

ZLDPF Financial Statistics

Sales & Book Value

Annual Sales: $49.77M
Cash Flow: $-45.01M
Price / Cash Flow: 0
Annual Sales: $18.83
Price / Book: 6.38

Profitability

EPS (TTM): -2.43390
Net Income (TTM): $-153.03M
Gross Margin: $46.98M
Return on Equity: -21.35%
Return on Assets: -19.03%

Zealand Pharma AS Earnings Forecast

Key Zealand Pharma AS Financial Ratios

  • The Gross Profit Margin over the past 17 years for ZLDPF is 94.41%.
  • The Selling, General & Administrative Expenses for ZLDPF have been equal to 26.21% of Gross Profit Margin.
  • The Research & Development expenses have been 199.80% of Revenue.
  • The Interest Expense is -3.54% of Operating Income.
  • The Net Earning history of ZLDPF is -205.30% of Total Revenues.
  • Per Share Earnings over the last 17 years have been positive in 7 years.

Zealand Pharma AS Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Biotechnology
Sector: Health Care
Current Symbol: ZLDPF
Website: zealandpharma.com

Debt

Debt-to-Equity Ratio: 0.03
Current Ratio: 35.49
Quick Ratio: 35.31

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ZLDPF Technical Analysis vs Fundamental Analysis

Sell
49
Zealand Pharma AS (ZLDPF) is a Sell

Is Zealand Pharma AS a Buy or a Sell?